Reverse phase protein array (RPPA) is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body ...

Hayward, Calif.-based Zyomyx released its Protein Profiling Biochip System and a compatible array for human cytokines in February. Consisting of the Assay 1200™ automated workstation, the Scanner 100™ ...

Cancer is one of the leading causes of death worldwide, affecting over 20 million individuals and killing 9.7 million in 2022 alone. Each of ~200 cancer types (and multiple subtypes) presents an ...

Led by Lisa Kubiak, RN, the Athens, Georgia clinic now provides Genesis Regenerative’s non-cellular RPA product and an expanded digital platform. I have studied stem cells and the potential they offer ...

Scientists at Northwestern University have developed a new detection technology on the nanometer scale that could lead to the next generation of proteomic arrays and new methods for diagnosing ...

Antibody-based reverse-phase protein arrays to quantitatively analyze specific protein pathways and their activation states with large sample sets (tissue or cells). Approximately 290+ validated ...